市場調査レポート
商品コード
1105750
ワクチンデリバリーデバイスの世界市場(2022年~2028年):デバイス別、投与経路別、地域別の市場規模調査と予測Global Vaccine Delivery Devices Market Size study, by Device by Route of Administration and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ワクチンデリバリーデバイスの世界市場(2022年~2028年):デバイス別、投与経路別、地域別の市場規模調査と予測 |
出版日: 2022年07月12日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のワクチンデリバリーデバイスの市場規模は、2021年に約60億3,000万米ドルとなり、2022年~2028年の予測期間中に7.50%以上の健全な成長率で拡大すると予想されています。
市場を牽引する主な要因には、予防接種プログラムの成長とその適用範囲の拡大、予防接種研究の増加、政府の支援と投資の増加、革新的なワクチンの開発、多数のキャンペーンやイニシアチブなどがあります。
当レポートは、世界のワクチンデリバリーデバイス市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。
List of figures
Global Vaccine Delivery Devices Market is valued approximately USD 6.03 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50 % over the forecast period 2022-2028. Growing immunisation programmes and their expanding coverage, increased vaccination research, increased government support and investment, development of innovative vaccines, and numerous campaigns and initiatives are some of the important drivers driving market expansion. Biotech and pharmaceutical firms, in collaboration with governments throughout the world, are developing a plan to address supply chain difficulties in vaccine distribution and the development of effective vaccines. The need to find and monitor a COVID-19 vaccine raised the interest in developing an effective and safe viral delivery method, or, ideally, numerous delivery systems. UNICEF, Gavi, and the WHO created the COVID-19 Vaccine Delivery Partnership in January 2022 to address the urgency of translating vaccine doses into protected and vaccinated populations. The alliance aims to provide immediate operational help to 34 countries with vaccination coverage of 10% or less as of January 2022. Overall, the collaboration aims to improve vaccination distribution and supply chain management in 92 countries. The rising demand for hepatitis A and B therapy, as well as meningitis and influenza, has moved the industry forward. Furthermore, the global spike in demand for COVID-19 immunisation created a substantial market potential. Overall, the COVID-19 pandemic had a favourable influence on the industry, and the introduction of booster vaccine doses is projected to fuel additional development. Increasing research and investment in vaccine development is also one of the market's main drivers. The Institute of Infection and Immunity of the Canadian Institutes of Health Research promotes and finances research initiatives focused at lowering the burden of infectious illnesses, allergies, and immune-mediated disorders. The institution contributes around USD 1 million per year in hepatitis C research, USD 45.7 million in pandemic influenza research collaborations, and USD 22.5 million in the CIHR HIV/AIDS Research Initiative. However, stringent compliance regulations limits market growth over the projection period of 2022-2028.
The key regions considered for the Global Vaccine Delivery Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. Growing vaccination coverage, increased spending in R&D for novel vaccines, and the high frequency of infectious illnesses are all driving market expansion. Furthermore, advanced healthcare infrastructure and widespread public and professional knowledge have contributed to the market's considerable share. MEA is predicted to develop at the quickest rate over the projection period because to a big patient pool, rising target population, high unmet demands, and improved regional infrastructure. Illnesses are becoming more common as a result of unhealthy lifestyles and an ageing population that is prone to infectious diseases.
Major market players included in this report are:
Becton Dickinson & Company
Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
PharmaJet
Vaxxas
Gerresheimer AG
SCHOTT AG
Corium International, Inc.
3M Company
Pfizer
Merk AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device:
Syringes
Jet Injectors
Other Devices
By Route of Administration:
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Other Vaccinations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Vaccine Delivery Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors